MSD eyeing Seagen acquisition, media reports
US-based biotech firm Seagen has benefitted on the stock exchange from rumors that pharmaceutical firm MSD was looking to buy.
by marketwire, translated by daniel pedersen
Pharmaceutical firm MSD is reported interested in buying US-based biotech firm Seagen, anonymous sources have told media Dow Jones News.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
MSD stops prostate cancer trial
For subscribers
.jpg&w=384&q=75)
